Prestige Consumer Healthcare, Inc. (PBH)
45.01
-0.25
(-0.55%)
USD |
NYSE |
Oct 05, 09:55
Prestige Consumer Healthcare Gross Profit Margin (Quarterly) : 49.11% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.11% |
| March 31, 2026 | 50.02% |
| December 31, 2025 | 53.70% |
| September 30, 2025 | 53.41% |
| June 30, 2025 | 54.16% |
| March 31, 2025 | 55.63% |
| December 31, 2024 | 53.76% |
| September 30, 2024 | 53.50% |
| June 30, 2024 | 52.53% |
| March 31, 2024 | 52.76% |
| December 31, 2023 | 53.87% |
| September 30, 2023 | 53.91% |
| June 30, 2023 | 53.39% |
| March 31, 2023 | 51.69% |
| December 31, 2022 | 52.32% |
| September 30, 2022 | 53.46% |
| June 30, 2022 | 55.47% |
| March 31, 2022 | 53.26% |
| December 31, 2021 | 54.22% |
| September 30, 2021 | 54.86% |
| June 30, 2021 | 56.93% |
| March 31, 2021 | 55.17% |
| December 31, 2020 | 55.66% |
| September 30, 2020 | 55.44% |
| June 30, 2020 | 55.71% |
| Date | Value |
|---|---|
| March 31, 2020 | 54.80% |
| December 31, 2019 | 54.34% |
| September 30, 2019 | 54.83% |
| June 30, 2019 | 55.13% |
| March 31, 2019 | 54.66% |
| December 31, 2018 | 54.90% |
| September 30, 2018 | 54.61% |
| June 30, 2018 | 52.58% |
| March 31, 2018 | 52.47% |
| December 31, 2017 | 51.94% |
| September 30, 2017 | 53.06% |
| June 30, 2017 | 53.13% |
| March 31, 2017 | 51.33% |
| December 31, 2016 | 54.76% |
| September 30, 2016 | 54.85% |
| June 30, 2016 | 54.76% |
| March 31, 2016 | 53.91% |
| December 31, 2015 | 55.30% |
| September 30, 2015 | 55.45% |
| June 30, 2015 | 55.44% |
| March 31, 2015 | 54.88% |
| December 31, 2014 | 53.94% |
| September 30, 2014 | 54.44% |
| June 30, 2014 | 54.16% |
| March 31, 2014 | 53.21% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 72.88% |
| Structure Therapeutics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.23% |
| Return on Assets | 4.65% |
| Return on Invested Capital | 5.52% |
| Profit Margin (Quarterly) | 10.98% |
| Operating Margin (Quarterly) | 19.77% |
| Return on Net Operating Assets | 4.80% |